Prokidney (PROK) Enterprise Value (2021 - 2026)

Prokidney (PROK) has reported Enterprise Value for 6 consecutive years, with $861.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 414.54% year-over-year to $861.4 million in Q2 2026; TTM through Jun 2026 was $861.4 million, a 414.54% increase from a year earlier, with the FY2025 full-year figure at $883.5 million, up 44.76% from the prior year.
• Enterprise Value was $861.4 million for Q2 2026 at Prokidney, up from $692.7 million in the prior quarter.
• Over five years, Enterprise Value peaked at $3.1 billion in Q1 2023 and troughed at $167.4 million in Q2 2025.
• A 5-year average of $1.0 billion and a median of $752.7 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value jumped 1115.36% in 2023 and plunged 87.27% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $1.5 billion in 2022, then sank by 70.47% to $452.1 million in 2023, then soared by 35.0% to $610.3 million in 2024, then jumped by 44.76% to $883.5 million in 2025, then decreased by 2.51% to $861.4 million in 2026.
• The last three Enterprise Value figures came in at $861.4 million (Q2 2026), $692.7 million (Q1 2026), and $883.5 million (Q4 2025), per Business Quant data.